These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 11871141)
1. [Arbekacin resistant gene, aacA/aphD, in Staphylococcus aureus is lost during in vitro passage]. Chen G; Fukuchi K; Wakuta R; Kubo S; Yasuhara T; Takagi Y; Gomi K Rinsho Byori; 2002 Jan; 50(1):79-84. PubMed ID: 11871141 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism for the enhancement of arbekacin resistance in a methicillin-resistant Staphylococcus aureus. Matsuo H; Kobayashi M; Kumagai T; Kuwabara M; Sugiyama M FEBS Lett; 2003 Jul; 546(2-3):401-6. PubMed ID: 12832077 [TBL] [Abstract][Full Text] [Related]
3. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)]. Tabata M; Shimizu M; Araake M; Ogawa H Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397 [TBL] [Abstract][Full Text] [Related]
4. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin. Inouye Y; Hashimoto M; Sugiyama M; Takesue Y; Santo T; Yokoyama T Hiroshima J Med Sci; 1994 Sep; 43(3):87-92. PubMed ID: 7534753 [TBL] [Abstract][Full Text] [Related]
6. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group]. Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193 [TBL] [Abstract][Full Text] [Related]
7. Dissemination of nosocomial multiple-aminoglycoside-resistant Staphylococcus aureus caused by horizontal transfer of the resistance determinant (aacA/aphD) and clonal spread of resistant strains. Udou T Am J Infect Control; 2004 Jun; 32(4):215-9. PubMed ID: 15175616 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus. Inoue M; Nonoyama M; Okamoto R; Ida T Drugs Exp Clin Res; 1994; 20(6):233-9. PubMed ID: 7758395 [TBL] [Abstract][Full Text] [Related]
10. Specificity of 4'''-acetylation by an aminoglycoside-modifying enzyme in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus. Fujimura S; Tokue Y; Takahashi H; Nukiwa T; Watanabe A Tohoku J Exp Med; 1998 Sep; 186(1):67-70. PubMed ID: 9915109 [TBL] [Abstract][Full Text] [Related]
11. [Necessity and usefulness of detection by PCR of mecA and aac(6')/aph(2") genes for identification of arbekacin-resistant MRSA]. Hotta K; Ishikawa J; Ishii R; Saitoh F; Kira K; Arakawa Y; Ike Y Jpn J Antibiot; 1999 Aug; 52(8):525-32. PubMed ID: 10587877 [TBL] [Abstract][Full Text] [Related]
12. In vitro activities of arbekacin, alone and in combination, against methicillin-resistant Staphylococcus aureus. Kono K; Takeda S; Tatara I; Arakawa K Jpn J Antibiot; 1994 Jun; 47(6):710-9. PubMed ID: 8072179 [TBL] [Abstract][Full Text] [Related]
13. A newly recognized acetylated metabolite of arbekacin in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus. Fujimura S; Tokue Y; Takahashi H; Nukiwa T; Hisamichi K; Mikami T; Watanabe A J Antimicrob Chemother; 1998 Apr; 41(4):495-7. PubMed ID: 9598784 [No Abstract] [Full Text] [Related]
14. Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes. Barada K; Hanaki H; Ikeda S; Yamaguchi Y; Akama H; Nakae T; Inamatsu T; Sunakawa K J Infect Chemother; 2007 Apr; 13(2):74-8. PubMed ID: 17458673 [TBL] [Abstract][Full Text] [Related]
15. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)]. Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320 [TBL] [Abstract][Full Text] [Related]
16. Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus. Watanabe T; Ohashi K; Matsui K; Kubota T J Antimicrob Chemother; 1997 Apr; 39(4):471-6. PubMed ID: 9145819 [TBL] [Abstract][Full Text] [Related]
17. [Reliability of disc-diffusion susceptibility testing for arbekacin, vancomycin and teicoplanin against methicillin-resistant Staphylococcus aureus]. Kouda M; Homma S; Udagawa I; Tamura K; Fukuhara J; Takeuchi M Jpn J Antibiot; 1999 Dec; 52(12):681-9. PubMed ID: 10695023 [TBL] [Abstract][Full Text] [Related]
18. Structures of enzymatically modified products of arbekacin by methicillin-resistant. Staphylococcus aureus. Kondo S; Tamura A; Gomi S; Ikeda Y; Takeuchi T; Mitsuhashi S J Antibiot (Tokyo); 1993 Feb; 46(2):310-5. PubMed ID: 8468247 [TBL] [Abstract][Full Text] [Related]
19. [The enzymatic mechanisms of resistance to aminoglycoside antibiotics in methicillin-cephem-resistant Staphylococcus aureus]. Matsuhashi Y; Yamamoto H Jpn J Antibiot; 1988 May; 41(5):523-9. PubMed ID: 3216474 [TBL] [Abstract][Full Text] [Related]
20. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. II. Isolation of arbekacin-resistant strain. Inouye Y; Morifuji K; Masumi N; Nakamura S; Takesue Y; Santou T; Yokoyama T Hiroshima J Med Sci; 1992 Dec; 41(4):79-85. PubMed ID: 1293073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]